Minimal toxicity of stabilized compacted DNA nanoparticles in the murine lung
Open Access
- 1 December 2003
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy
- Vol. 8 (6), 948-956
- https://doi.org/10.1016/j.ymthe.2003.09.002
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotidesEuropean Journal of Immunology, 2003
- Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartmentsEuropean Journal of Immunology, 2002
- CpG-Depleted Plasmid DNA Vectors with Enhanced Safety and Long-Term Gene Expression in VivoMolecular Therapy, 2002
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12European Journal of Immunology, 2001
- Reduced Inflammatory Response to Plasmid DNA Vectors by Elimination and Inhibition of Immunostimulatory CpG MotifsMolecular Therapy, 2000
- Bacterial DNA is implicated in the inflammatory response to delivery of DNA/DOTAP to mouse lungsGene Therapy, 2000
- CpG DNA and LPS induce distinct patterns of activation in human monocytesGene Therapy, 1999
- CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract.JCI Insight, 1997
- Activation of the Complement System by Synthetic DNA Complexes: A Potential Barrier for Intravenous Gene DeliveryHuman Gene Therapy, 1996